TRPV1 antagonists including dihydroxy substituent and uses thereof
US9394293B2 · kind B2 · utility
3Cited by
46References
32Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 9, 2012 |
| Grant date | Jul 19, 2016 |
| Priority date | — |
| Expiry date | Aug 30, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure relates to Compounds of Formula (I):and pharmaceutically acceptable derivatives thereof wherein Ar1, Ar2, L1, L2, X, R3, R22, and m are as defined herein, compositions comprising an effective amount of a Compound of Formula (I), and methods for treating or preventing a condition such as pain, UI, an ulcer, IBD and IBS, comprising administering to an animal in need thereof an effective amount of a Compound of Formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.